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Summary
Legionella pneumophila is a facultative intracellular bacterial pathogen that parasitizes human
monocytes and alveolar macrophages. Previous studies from this laboratory have shown that
monocyte complement receptorsCRI andCR3 and complement component C3 in serum mediate
L. pneumophila phagocytosis. In this study, we have explored C3 fixation to L. pneumophila . We
developed a whole-cell enzyme-linked immunosorbent assay (ELISA) to measure C3 fixation
to the bacterial surface. By this assay, C3 fixes to L. pneumophila that are opsonized in fresh
nonimmune serum, andC3 fixation takes place via the alternative pathway of complement activation .
Immunoblot analysis of opsonized L. pneumophila indicated that C3 fixes selectively to specific
acceptor molecules ofL. pneumophila . Consistent with this, when nitrocellulose blots of whole
L. pneumophila or bacterial components are incubated in fleshnonimmune serum, C3 fixes exclusively
to the major outer membrane protein (MOMP) of L. pneumophila, a porin ; C3 does not fix
toL . pneumophila LPS on these blots . To further explore the role ofMOMP in C3 fixation and
phagocytosis, we reconstituted purifiedMOMP into liposomes . By the ELISA, MOMP-liposomes,
but not plain liposomes lacking MOMP, avidly fix C3 . Consistent with a dominant role for
MOMP in C3 fixation, MOMP-liposomes form a C3 complex of the same apparent molecular
weight as wholeL. pneumophila innonimmune serum . Opsonized radioiodinated MOMRliposomes
avidly adhere to monocytes, and adherence is dose dependent upon serum. By electron microscopy,
opsonized MOMP-liposomes are efficiently phagocytized by human monocytes, and phagocytosis
takes place by a conventional appearing form of phagocytosis . This study demonstrates that C3
fixes selectively to theMOMP ofL, pneumophila, and that, in the presence ofnonimmune serum,
MOMP can mediate phagocytosis ofliposomes and, potentially, phagocytosis ofintactL. pneumophila
by human monocytes.
D
tonella pneumophila, the etiologic agent ofLegionnaires'
disease, is a facultative intracellular bacterial pathogen
that parasitizes human monocytes and alveolar macrophages
(1, 2) . The bacterium gains access to these mononuclear phago-
cytes by phagocytosis. In the case ofL . pneumophila, the in-
gestion process has an unusual morphology and has been
termed "coiling phagocytosis" (3) . Once intracellular, the bac-
terium resides in a ribosome-lined phagosome of relatively
high pH that does not fuse with lysosomes (4-6) . L. pneu-
mophila multiplies in this specialized phagosome and ultimately
destroys the host cell .
Previous studies from this laboratory have demonstrated
that complement receptors CR1 andCR3 onhumanmono-
cytes mediate phagocytosis ofL. pneumophila (7). These re-
ceptors recognize fragments of complementcomponentC3 ;
CRI is the primary receptor for C3b, and CR3 is the pri-
mary receptor for iC3b. mAbs against these receptors inhibit
phagocytosis ofL. pneumophila and, consequently, intracel-
lular multiplication of the bacteria in human monocytes. Al-
though complement receptors may recognize molecules other
than complement components, previous studies have indi-
cated that complement component C3 mediates phagocytosis
ofL. pneumophila . Consistent with this, phagocytosis ofL.
pneumophila is serum dependent, mediated by a component
in nonimmune serum capable offixing to the bacterium, and
markedly reduced in heat-inactivated serum (7) . However,
previous studies using an immunofluorescence assay did not
detect C3 on the surface of L. pneumophila in nonimmune
serum (8) .
In this study, we first sought to demonstrate that C3 is
fixed to L. pneumophila . To achieve this goal, we developed
a highly sensitive whole cell ELISA to detect C3 on theL.
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that C3 is fixed to thebacterium and that fixation takes place
by the alternative pathway of complement activation .
We also sought in this study to identify acceptor mole-
cule(s) for C3 on theL. pneumophila surface . Although, in
theory, any surface protein or LPS molecule with an acces-
sible COON or NH2 group might serve this purpose, we
found that C3 is fixed predominantly to a single molecule
on L. pneumophila . We shalldemonstrate thatC3 in nonim-
mune serum is fixed selectively to the majoroutermembrane
protein (MOMP)t of the bacterium, a porin . We shall also
show that liposomeswith purifiedMOMP incorporated into
theirmembranes readily fix C3, and when so opsonized, the
liposomes are efficiently phagocytized byhumanmonocytes .
Materials and Methods
Reagents.
￿
Goat anti-human C3 (Atlantic Antibodies, Scarbor-
ough, ME); alkaline phosphatase (AP)-conjugated rabbit anti-goat
IgG and AP-conjugated goat anti-rabbit IgG (Cappel Organon
Teknika Corp., Westchester, PA); horseradish peroxidase (HR-P)-
conjugated goat anti-rabbit IgG, HRP-conjugated rabbit anti-goat
IgG, andHRP-conjugated goat anti-mouse IgG (Bio-Rad Labora-
tories, Richmond, CA); mousemonoclonal anti-humaniC3b neoan-
tigen (Cytotech, San Diego, CA) ; chicken anti-human C3 (Accurate
Chemical& Scientific Corp., Westbury NY); HRP-conjugated goat
anti-chicken IgG (Bethyl Labs Inc., Montgomery, TX); nitrocel-
lulose blotting paper (Schleicher& Schnell, Inc ., Keene, NH) ; and
diphytanoylphosphatidylcholine (PC) andegg phosphatidylethanola-
mine (PE) (Avanti Polar Lipids, Inc., Birmingham, AL)were pur-
chased. All other reagents were obtained from commercial sources
and were reagent-grade quality, except as noted.
Bacteria .
￿
L. pneumophila, Philadelphia 1 strain, was grown in
embryonated hens' eggs, harvested, tested for viability and con-
taminants, and stored at -70°C, as described (1) . For experimental
use, egg yolk-grown L. pneumophila was cultured one time only
on charcoal yeast extract agar, as described (1) . Colonies were re-
moved from the surface of several agar plates in sterile PBS and
harvestedby centrifugation at 4°Cat 10,000 g . Theharvested bac-
teria were washed twice more, resuspended in PBS, quick-frozen
in a dry ice-ethanol bath, and stored at -70°C .
L . pneumophila Membranes, MOMP, andLPS .
￿
L. pneumophila
membranes were prepared by making and lysing spheroplasts, and
MOMP and LPS were purified from the membranes as described
(9, 10) .
Antisera .
￿
Antisera against theMOMP andLPSofL.pneumophila
were obtained by immunizing 2-kg New Zealand White rabbits
subcutaneously with purifiedMOMP or purified LPS. Rabbitswere
initially injected with 100 hg MOMP or 50 1~g LPS mixed 1:1
with CFA, andthen boosted2 and4 wk later with 100 hg MOMP
or 50 gg LPS mixed 1:1 with IFA .
Serum.
￿
Fresh humanserum wasobtained from normal nonim-
mune donors and stored at -70°C until use. Serum aliquots were
thawed on ice and used immediately, or were heat inactivated at
56°C for 30 min before use .
ELISAforC3 Fixation toL. pneumophila andLiposomes.
￿
L . pneu-
mophila (101 bacteria/ml) were incubated for 60 min at 37°C in
fresh nonimmune human serum, fresh serum containing 10 mM
' Abbreviations used in this paper: AP, alkaline phosphatase; HRP, horse-
radish peroxidase; MOMP, major outer membrane protein; PC, diphy-
tanoylphosphatidylcholine ; PE, egg phosphatidylethanolamine .
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EDTA, fresh serum containing 10 mM EGTA and 7MM MgCl2,
heat-inactivated serum, or PBS. Bacteria were harvested by cen-
trifugation, washed twice in PBS, and resuspended in PBS at a final
concentration of 101 bacteria/ml . 0.1-ml aliquots of the bacterial
suspension were dispensed in triplicate to wells of a96-well tissue
culture plate and allowed to evaporate to dryness under a laminar
flow hood . Nonspecific protein binding sites were then blocked
by the addition of PBS containing 3% OVA for a minimum of
6 h . Theblocked wellswere washed three times with PBS, incubated
with primary antibody for 1 h at room temperature, washed three
timesmore in PBS, incubatedwith AP-conjugated secondary anti-
body for 1 h at room temperature, washed again, and incubated
with phosphatase substrate. The color was allowed to develop for
30 min, and then the reaction was terminated by the addition of
NaOH to a final concentration of 0.2 N. Absorbance at 405 nm
was measured immediately.
Liposomes with andwithoutMOMP incorporated in theirmem-
branes were incubated for 60 min at 37°C in 10% fresh serum
or in 10% fresh serum containing 10mM EDTA . The liposomes
were harvested by ultracentrifugation, washed 3 times with PBS,
and resuspended in PBS . One-tenth ml aliquots (1.5-1 .8 ug total
phospholipid) were dispensed in triplicate wells, evaporated to dry-
ness, and assayed for C3 as above.
SDS-PAGE.
￿
SDS-PAGE wasperformedaccording to Laemmli
(11) as modified byAmes (12) . Separating gels contained 4M urea
and either 7.5% or 14% polyacrylamide . Samples were solubilized
in SDS-PAGE sample buffer containing 62 .5 mM Tris-HCl, 10%
glycerol, 2% SDS, 2mM EDTA, 5% 2-ME, and either bromphenol
blue or pyroninY as a tracking dye. Molecular weight standards
(Sigma Chemical Co., St . Louis, MO) were as follows- BSA, 66
kD ; OVA, 45 kD ; glutaraldehyde-6-phosphate dehydrogenase, 36
kD ; carbonic anhydrase, 29 kD ; trypsinogen, 24 kD ; and a-lac-
talbumin, 14.2 kD. Prestained molecular weight standards (Bio-
Rad Laboratories), calibrated before use, were as follows: prestained
carbonic anhydrase, 37kD; prestained OVA, 52kD ; prestained BSA,
87 kD.
Immunoblot Analysis of C3 Fixation to L. pneumophila and Lipo-
somes . L. pneumophila (3.6 x 101 bacteria) or liposomes with or
withoutMOMP (5 ug phospholipid) were opsonized by incuba-
tion in serum at 37°C . In some cases, PMSF wasadded after incu-
bation to prevent proteolytic breakdown ofC3 . The bacteria and
liposomes were vigorously washed in PBS and subjected to SDS-
PAGE . The separated proteins were then electroblotted to nitrocel-
lulose paper for 12-18 h at 0.25 A at 4°C. The blots were first
incubated in PBS containing 1% BSA at 4°C overnight to block
nonspecific protein binding sites, and then incubated at 4°C for
12-18hwith primary antibody diluted in PBScontaining1% BSA,
0.02% SDS, and0.1% Triton X-100 . The blots were washed three
times for 10 min each in PBS containing 0.2% BSA, 0.02% SDS,
and0.1% Triton X-100, and then incubated at 4°Cfor 18h with
enzyme-conjugated secondary antibody, diluted in PBS containing
1% BSA, 0.02% SDS, and 0.1% Triton X-100 . The blots were
washed three times as above and substrate was added.
In some experiments, radiolabeled C3, kindly provided by Jo
Ellen Schweinle andKeith Joiner (Yale University), was added to
serum during the opsonization step, and autoradiographs of the
SDS-PAGE gel were obtained .
Analysis ofC3 Fixation to ImmunoblottedL. pneumophila Compo-
nents. Triplicate sets of wholeL . pneumophila, L. pneumophilamem-
branes, isolated MOMP, and isolated LPSwere subjected to SDS-
PAGE (14% polyacrylamide-4Murea gels) and the separated mol-
ecules immunoblotted to nitrocellulose paper. The blots were in-
cubated overnight at 4°C in PBS containing 1% BSA to block
C3 Fixes to the Major Outer Membrane Protein of Legionella pneumophilanonspecific protein binding sites. One set ofblots was incubated
in 10% fresh human serum in PBS for 60 min at 37°C, washed
with PBS three times for 15 min each to remove unbound serum
components, andprobed with aprimary antibody againstC3 . The
other two sets of blots were not incubated in serum ; one of these
was probed with aprimary antibody againstMOMP, andthe other
was probed with a primary antibody againstLPS . HRP-conjugated
secondary antibodies were added and the blots developed as de-
scribed in the above assay.
Construction ofLiposomes with and withoutMOMP .
￿
Liposomes
were constructed according to the cholate dilution procedure of
Racker et al . (13) . PC and PE were dissolved separately in chloro-
form/methanol (2 :1 [vol/vol]) and mixed at a ratio of four parts
PC to one part PE (wt/wt) . The mixed lipids (6.5 mg total phos-
pholipid) were dried underN2 , diluted in 195 Al PBS, and soni-
cated to clarity at 4°C . When liposomes were constructed with
MOMP, the sonicate was mixed with MOMP at a ratio of 50:1
(wt/wt) phospholipid/protein . Cholate was added to a final con-
centration of0.1%, and the mixture incubated at 4°C for30 min.
The liposomes were diluted to 25 times the sample volume, in-
cubated for 10 min at room temperature, pelleted at 192,000 g,
washed once, and resuspended in PBS.
Total phospholipid in liposomes was quantitated by the method
of Raheja et al . (14) using a 4:1 mixture ofPC and PE as a stan-
dard . Duplicateliposome sampleswere extracted twicewith chlo-
roform/methanol, (2 :1 [vol/vol]) . Theorganic phases were pooled
and evaporated to dryness in acid-cleaned glass tubes for use in the
assay.
Total protein in liposomes was quantitated by the method of
Lowry et al . (15) using BSA as a standard . The aqueous phases
from extracted liposomes were used to measure incorporated protein.
Preparation and Opsonization ofRadioiodinatedMOMP-Liposomes.
In studies on adherence of MOMP-liposomes to human monocytes,
liposomes were constructed as above, but with radioiodinated
MOMP. PurifiedMOMP was iodinated with
'251 by coupling with
Bolton-Hunter reagent (N-succinimidyl 3-(4-hydroxy, 5-['251]-
iodophenyl)propionate) . MOMP (100 Fig) in0.1M borate buffer,
pH 8.5, was reacted at 0°C for 30 minwith 250ACiBolton-Hunter
reagent that hadbeen dried onto the surface of a glass tube . The
reaction was terminated with the addition of 0.1M borate buffer,
pH 7.5, containing 0.2 M glycine . The iodinated MOMP was
precipitated from 80% ethanol at -70°C, harvested by centrifu-
gation, and resuspended at 1 P .g/A1 in PBS . Liposomes containing
radioiodinated MOMP (sp act 3-8 x 10" cpm/FAg) were opsonized
for60min at 37°C in varying concentrations of fresh serum, har-
vested by ultracentrifugation, and washed twice in PBS.
Assay for Adherence of Opsonized MOMRLiposomes to Human
Monocytes. Human mononuclear cells were isolated from fresh
heparinized blood as described previously (1) . Mononuclear cells
(3 x 106/coverslip) in RPMI 1640 containing 25 mM Hepes and
20% autologous serum were applied to sterile coverslips in 24-well
tissue culture plates, and incubated in 5% CO2 at 37°C for 60
min . The adherent monocyteswere washed several times with RPMI
containing 25mM Hepes to remove nonadherent cells and serum
components and then incubated under serumless conditions with
opsonized 125I-MOMP-containing liposomes (58,000 cpm, 2 Fcg
phospholipid) at 37°C in 5% CO2 under rotation at 100 rpm .
After60 min, themonocytes were washed thoroughly with RPMI
to remove unbound liposomes, and monocyte-associated counts
per minute were determined. All experiments were performed in
triplicate .
Electron Microscopic Study ofPhagocytosis ofLiposome-MOMP-C3
Complexes.
￿
Liposomes containing MOMP (10 hg phospholipid)
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were incubated in 10% freshserumfor60 min at 37°C, harvested
by ultracentrifugation, washed thoroughly, and suspended in PBS .
Mononuclear cells (7.2 x 10 5) were gently pelleted and chilled to
0°C. Opsonized liposomes, also at 0°C, were layered over the
mononuclear cells and pelleted at 325,000g for 15 min . Thesamples
were shifted to 37°C to allow phagocytosis to proceed, and then
fixed for electron microscopy after 3 or 6 min. Controls included
plain liposomesincubated with serum under the same conditions
and MOMP-liposomes incubated in serum containing EDTA .
Samples were fixed for electron microscopy with a solution con-
sisting of 1% OSO4 (two parts) and 2.5% glutaraldehyde (one
part) in0.1Mcacodylate buffer, pH 7.4, stained with 0.25% uranyl
acetate in 0.1 M sodium acetate buffer, pH 6.3, and dehydrated
with ethanol . The samples were infiltrated andembedded in Spur
medium, sectioned, and stained with lead citrate and uranyl ace-
tate. Sections were examined with an electron microscope (JEM-
100 CX ; JEOL, Ltd., Tokyo, Japan) .
Results
L . pneumophila Fixes Complement Component C3 to its Sur-
face. To detect C3 on the surface ofL . pneumophila, we de-
veloped a sensitive whole bacterial cell ELISA . To minimize
alterations of the bacterial cell surface, we applied intact, op-
sonized bacteria to microtiter wells in solution and then al-
lowed the solution to evaporateto dryness . We therebyavoided
a harsh chemical treatment that might denature or oxidize
delicate surface structures .
Bacteria opsonized in fresh nonimmune serum readily fixed
C3 (Fig . 1) . In contrast, bacteria incubated in buffer only
did not demonstrate thepresence of C3, and bacteria opsonized
in heat-inactivated serum exhibited only a small, but repro-
ducible amount ofC3 fixation . C3 associated with thebac-
teriawas notremovedby washingwith detergents (2% Triton
X-100, Zwittergent 3-14, or SDS) . The amount ofC3 fixed
to bacteria incubated in fresh serum was proportional to the
the serum concentration (data not shown) . Bacteria used in
these assays were freshly thawed, viable organisms . Interest-
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￿
L. pneumophila fixes
complement componentC3 to its
surface. L . pneumophila was in-
cubated for 60 min at 37°C in
fresh, nonimmunehuman serum,
in heat-inactivated serum, or in
PBS. The bacteria were washed
and used as antigen in an ELISA
for C3 as described in the text .
Data are the mean ± SD of tripli-
cate measurements .ingly, heat-killed and formalin-killedL . pneumophila also fixed
C3 in the same way (data not shown) .
L. pneumophila Fixes Complement ComponentC3 by the Al-
ternative Pathway ofComplement Activation. To determine if
C3 fixation occurs by the classical or alternative pathway of
complement activation, we assayed C3 fixation to L. pneu-
mophila that were incubated in fresh serum alone, in fresh
serum containing 10 mM EGTA and 7 MM MgC12 (condi-
tions under which classical pathway activation is abolished
but alternative pathway activation proceeds), in fresh serum
containing 10 mM EDTA (conditions under which both
pathways are abolished), or in buffer only. Bacteria opsonized
in fresh serum or in serum containing Mgt+-EGTA fixed
equivalent amounts ofC3 (Fig. 2) . As expected, bacteria in-
cubated in serum containing EDTA exhibited background
levels ofC3 fixation . These data indicate thatL. pneumophila
fixes C3 via the alternative pathway of complement activation.
C3 Is Fixed Selectively to an Acceptor Molecule on theL. pneu-
mophila Surface . Complement component C3 is a 195-kD
protein molecule composed of two disulfide-linked chains:
a 120-kD a chain, and a 75-kD R chain (Fig. 3) . Fixation
ofC3 to the bacterial surface entails the formation of a cova-
lentbondbetween the active thiolester site on theC3a chain
and a C3 acceptor molecule on the bacterium . After fixa-
tion, the C3b thus formed may be further processed to
iC3bt and iC3b2 upon sequential cleavage of the a chain.
These C3-derived fragments remain covalently attached to
the surface acceptor molecule and contain ever smaller por-
tions of theC3a chain . Under specific conditions not present
in our experiments, iC3b2 may be further degraded .
To explore C3 fixation to the L. pneumophila surface fur-
ther, we used immunoblot analysis to search for covalent com-
plexes ofL. pneumophila acceptor molecules and C3 . We in-
cubatedL. pneumophila with serum, vigorously washed the
bacteria, separated the bacterial proteins by SDS-PAGE, blotted
them onto nitrocellulose paper, and probed the blots for C3-
containing molecules . We reasoned that under reducing con-
ditions, both the disulfide bond linking the a and (3 chains
of C3 and the disulfide bond linking the 43- and 46-kD a
chain fragments to the portion ofthea chain covalently bound
to an acceptor molecule would be broken (Fig. 3) . This would
liberate the75-kDQ chain, and if iC3b is formed, the 46-kD
(iC3bt) and 43-kD (iC3b2) a chain fragments (from the a
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L . pneumop7Eila fixes
C3 by the alternative pathway of
complement activation. L. pneu-
mophila was incubated for 60 min
at 37°C in fresh nonimmune
human serum, in PBS, in fresh
serum containing 10mM EDTA,
or in fresh serum containing 10
mM EGTA and 7 MM MgC12 .
The washed whole bacteria were
used as antigen in an ELISA for
C3, as in Fig. 1 . Data are the mean
± SD for triplicate measurements .
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￿
Fixation andcleavage ofcomplement component C3 to a puta-
tive acceptor molecule. C3 consists of a 120-kD a chain and a 75-kD /3
chain linked by a disulfide bridge . C3 convertase, formed as a result of
classical or alternative complement pathway activation, cleaves C3 to Cab,
releasing C3a . The cleavage activates an internal thiolester within the a
chain ofCab, and this thiolester forms covalentbonds with availableCOOH
or NH2 groups of appropriate acceptor molecules. Once fixed to an ac-
ceptor molecule, the a chain of C3b may undergo additional processing.
In the presence of serum factorH or ofCR1, factor I cleaves the a chain
of C3b generating iC3bl . Under the same conditions, factor I cleaves the
a chain at an additional site near the site of the first cleavage, generating
iC3b2 . This liberates C3f, a 3-kD fragment, from the 46-kD portion of
the a chain, reducing it to 43 kD .
chain-acceptor molecule complex) . IfC3b is formed, the ot
chain-acceptor molecule complex would have a molecular
mass equal to the molecular mass of the acceptor molecule
plus 110 kD. If iC3b is formed, the complex would have a
molecular mass of the acceptor molecule plus 68 kD.
Immunoblot analysis confirmed that C3 was fixed to the
bacterium, and revealed that C3 was fixed selectively to a
specific acceptor molecule (Fig. 4) . Immunoblots probed with
polyclonal anti-C3 antibodies revealed the presence ofthe 75-
kD /3 chain, the 43- and 46-kD fragments of the a chain
ofiC3b, and a prominent new 150-kD C3-containing mole-
cule, presumably consisting oftheC3a chain covalently linked
to anL. pneumophila acceptor molecule (Fig . 4, laneA) . The
C3-containing bands formed during opsonization of viable,
freshly thawed bacteria were identical in both molecular mass
and amount to those formed during opsonization o£bacteria
passed one time on agar and freshly harvested . Immunoblots
probed with an anti-iC3b mAb that recognizes a site on theFigure 4 .
￿
Opsonized L . pneu-
mophila contain a high molecular
weight C3-acceptor molecule
complex. L . pneumophila was op-
sonized in 5% fresh nonimmune
serum for 15 min at 37°C, and
PMSF was added to prevent pro-
teolytic processing of fixed com-
plement . The bacteria were
washed, subjected to SDS-PAGE
on a 7.5% polyacrylamide-4 M
urea gel, and blotted to nitrocel-
lulose. The blots were probed
with polyclonal anti-C3 (lane A)
or an anti-iC3b mAb (lane B),
which recognizes a portion of the denatured a chain near the thiolester
linkage site . Lane C contains a native C3 standard (ot chain, 120 kD; (3
chain, 75 kD) probed with polyclonal anti-C3 antibody. Molecular mass
standards in kilodaltons are indicated next to the figure .
ct chain of iC3b (and denatured Cab) also revealed the pres-
ence of the 150-kD band, confirming that this band contains
the relevant portion of the C3 a chain (Fig. 4, lane B) .
Whether the 150-kD band contains the 110-kD a chain of
C3b or the 68-kD a chain ofiC3b linked to an acceptor mol-
ecule could not be determined by this assay.
To examine the possibility that polyclonal anti-C3 anti-
bodies crossreact with L . pneumophila molecules, we probed
immunoblots of unopsonized L . pneumophila with anti-C3.
Neither the polyclonal goat anti-C3 antibody nor a more sen-
sitive polyclonal chicken anti-C3 antibody (see below) de-
tected bands on these immunoblots, ruling out the possi-
bility of a crossreaction between C3 and L . pneumophila .
To further confirm these results, we added radiolabeled C3
to serum during the opsonization step and obtained autora-
diographs of the electrophoresed proteins. The autoradiographs
revealed the presence of the 150-kD band (data not shown) .
The autoradiograph also revealed the presence of a 110-kD
band that we subsequently observed on immunoblots ofop-
sonizedL . pneumophila and MOMP-liposomes when we used
a more sensitive chicken anti-C3 antibody (see Fig . 7 below) .
The thiol ester site in the C3 a chain can undergo two
separate reactions : one is the formation of an ester linkage
with oxygen-containing moieties, the other is the formation
of an amide bond with nitrogen-containing species . The
O-linked ester bond is labile to disruption by strong nu-
cleophiles (such as hydroxylamine or methylamine) . The amide
linkage is not susceptible to such attack (16, 17) . This affords
a convenient way to determine the type of linkage formed
in the C3-acceptor molecule complex . To explore this, we
opsonized L . pneumophila for 15 min at 37°C in fresh serum,
washed the bacteria vigorously, incubated them in 1.0M hy-
droxylamine in 1% SDS for 30 min at 37°C, washed them,
and immunoblotted as described above. Samples of the hy-
droxylamine-treated bacteria contained all theC3 bands seen
in the untreated samples, with no significant decrease in
amount (data not shown) . This same treatment released C3
from the surface ofopsonized group B Streptococcus . This in-
dicated that C3 fixation to theL . pneumophila acceptor mole-
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cule takes place through an amide bond and suggested that
the acceptor molecule is a protein rather than a carbohydrate.
MOMP on Nitrocellulose Blots Uniquely Fixes C3 . To ex-
plore which L . pneumophila component serves as an acceptor
molecule for C3, we blotted samples of wholeL. pneumophila,
L. pneumophila membranes, isolated MOMP, and isolated LPS,
then incubated the blot itself in fresh serum, washed it, and
probed the blot for C3 with anti-C3 antibody (Fig. 5 A) .
C3 bound exclusively toMOMP on the blot (Fig. 5A, lanes
a-d) . C3bound to both themonomeric 29-kDMOMP band
in purifiedMOMP (Fig . 5 A, lane b), whole membranes (lane
c), and whole bacteria (lane d), as well as to a higher order
MOMP aggregate found only in whole bacteria (lane d, ar-
rowhead) . C3 even bound to the small amount ofMOMP
that routinely contaminates the LPS preparation (lane a) . The
anti-C3 antibody does not detect MOMP or any other mol-
ecule in blotted samples of unopsonized L . pneumophila (data
not shown) .
The identification of the 29-kD C3-fixing band asMOMP
was confirmed by probing a duplicate blot (untreated with
serum) with an anti-MOMP antibody that recognizes only
monomeric MOMP (Fig . 5 B) . Another anti-MOMP an-
tiserum, raised against a reduced, denatured form ofMOMP,
does recognize the higher order aggregates ofMOMP in whole
bacteria (data not shown) . In contrast to MOMP, the LPS
ofL . pneumophila (the other major molecule on the surface
of the bacteria) does not fix C3 . The location ofLPS was
revealed on a third blot probed with anti-LPS antibody (Fig.
5 C) . The LPS ladder can be clearly seen as a series ofclosely
spaced bands rising from just behind the dye front of the
blot . The entire LPS ladder (with its contaminating MOMP)
displays a distinctly different pattern than blots stained with
anti-C3 (Fig. 5 A) or anti-MOMP antibody (Fig . 5 B) . These
data show that MOMP selectively fixes C3 .
The finding that a protein and not LPS fixes C3 is consis-
tent with the results of the hydroxylamine release study, which
indicated that C3 is covalently bound to a protein .
MOMP-containing Liposomes Fix C3.
￿
Our finding that
MOMP on immunoblots selectively fixes C3 prompted us
to explore the capacity of liposomes with isolated MOMP
incorporated into their membranes to fix C3 and serve as a
model system for study ofL. pneumophila phagocytosis . We
reconstituted purifiedMOMP into unilamellar liposomes con-
structed ofPC and PE at a 4 :1 ratio (wt/wt) . This particular
lipid mixture is considered to be in the fluid state and was
used in the studies that demonstrated thatMOMP forms a
functional porin in artificial membranes (9) . We confirmed
by an ELISA that MOMP was present in liposomes recon-
stituted with MOMP (Fig. 6 B) .
We then used theELISA for C3 to determine the capacity
ofMOMP-containing liposomes fo fixC3. We incubated lipo-
somes containing MOMP and liposomes not containing
MOMP (plain liposomes) in fresh serum in the presence or
absence ofEDTA, washed them twice in buffer, and probed
for C3 byELISA . All liposome preparations contained equiva-
lent amounts of total phospholipid. As seen in Fig. 6 A,
MOMP-containing liposomes fixed almost 10 times as much
C3 as plain liposomes lackingMOMP C3 fixation byMOMP-liposomes was abolished in serum containing EDTA, as ex-
pected . Interestingly, the small amount ofC3 fixed by plain
liposomes also decreased in serum containing EDTA, sug-
gesting that this fixation results from low-level activation of
C3, and does not represent nonspecific sticking of C3 to
liposomes .
MOMP-Liposomes Form a C3 Complex ofthe Same Apparent
Molecular Weight as that Formed on IntactL . pneumophila . To
evaluate C3 acceptor molecule complexes formed on MOMP-
liposomes, we performed immunoblotting experiments com-
paring opsonized MOMP-liposomes, opsonized plain lipo-
somes, and opsonized L. pneumophila . We incubatedL . pneu-
mophila and liposomes in fresh serum with and without EDTA,
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MOMP-containing liposomes fix C3 . (A) Liposomes with
incorporated MOMP (solid ban) or liposomes withoutMOMP (open bars)
were incubated in fresh nonimmune human serum with and without 10
mMEDTAfor 60 min at 37°C . The liposomes were harvestedby ultracen-
trifugation, washed to remove unbound serum components, and used as
antigen in an ELISA for C3 . (B) Liposomes with MOMP (solid ban) or
withoutMOMP (open ban) were used as antigen in an ELISA forMOMP .
Figure 5 .
￿
C3 fixes selectively toMOMPinblottedsamples
of whole bacteria, whole membranes, purified MOMP, and
purified LPS. Whole bacteria (lanes d), whole L .pneumophila
membranes (lanes c), purifiedMOMP (lanes b), and purified
LPS (lanes a) were subjected to SDS-PAGE on 14% poly-
acrylamide-4 M urea gels and blotted to nitrocellulose. (A)
The blot was incubated in 10% fresh serum for 60 min at
37°C, washed vigorously, and probed with polyclonal anti-
C3 antibody. (B and C) The blots were not treated with
serum . B was probed with anti-MOMP antibody, andC was
probedwith anti-LPS antibody. Molecular mass standards in
kilodaltons are indicated to the right of C.
washed the particles, blotted the proteins, and probed the
blots for C3 (Fig. 7) . In these studies, we used a polyclonal
chicken anti-C3 antibody instead of a polyclonal goat anti-
C3 antibody used in the earlier studies because it appeared
to have greater sensitivity. With whole opsonized L . pneu-
mophila (Fig. 7, lane A), the chicken anti-C3 antibody de-
tected not only the high molecular mass 150-kD band seen
in Fig. 4, but also a lower molecular mass band of-110 kD .
It also detected the 75-kD0chain and 43- and 46-kD a chain
fragments . With MOMP-liposomes (Fig . 7, lane B), the
chicken anti-C3 antibody detected a prominent 150-kD band
of the same apparent molecular weight as the one detected
on whole opsonized L . pneumophila ; in addition, this anti-
body detected the 75- and 43-kD bands . With plain lipo-
somes (Fig . 7, lane C), the chicken anti-C3 antibody detected
only faint 75- and 43-kD bands ; the 150-kD band was ab-
sent . The presence of a small amount of the 43-kD a chain
fragment ofC3 on plain liposomes confirms that plain lipo-
somes fix some C3 specifically, as suggested by the ELISA
data shown in Fig. 6. The absence of the 150-kD band on
plain liposomes confirms that this band onMOMP-liposomes
isMOMP dependent . On duplicate blots, the anti-iC3b mAb
that recognizes only the portion of the denatured a chain
attached to an acceptor molecule also detected the 150-kD
band on L . pneumophila and MOMP-liposomes, confirming
that this band contains the a chain of C3 . The addition of
EDTA to the serum abolished C3 fixation to intact L . pneu-
Figure 7 . Opsonized L. pneu-
mophila and opsonized MOMP-
liposomes contain C3-acceptor mol-
ecule complexes of similar molecular
weight . Whole L. pneumophila (lanes
A and D), MOMP-liposomes (lane B),
or plain liposomes (lane C) were op-
sonized in 10% fresh serum at 37°C
for 60 min, harvested, washed twice
in PBS, subjected to SDS-PAGE on
a 7.5% polyacrylamide-4M urea gel,
and blotted onto nitrocellulose . The
blot was probed with a polyclonalchicken anti-human C3 antibody. Mo-
lecular mass standards are indicated in kilodaltons . TD, tracking dye .
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￿
Opsonized MOMP-liposomes adhere to human monocytes.
1251-MOMP-liposomes were opsonized for 60 min at 37°C in various con-
centrations of serum. The liposomes were thoroughly washed, and then
added to freshly isolated adherent monocytes as described in the text. After
60 min, the coverslips were thoroughly washed, and monoryte-associated
radioactivity was counted . All experiments were performed in triplicate.
The percentage of counts retained on the coverslips are plotted as a func-
tion ofthe serum concentrationused to opsonize the liposomes. Nonspecific
binding of opsonized liposomes to coverslips in control wells not con-
taining monorytes ranged from 1 .2 to 1.5% . Bars represent the SEM.
Figure 9.
￿
Opsonized MOMPLiposomes are phagocytized by human monocytes. MOMPliposomes were opsonized for 60 min at 37°C in 10%
serum, thoroughly washed, incubated with freshly isolated mononuclear cells, and processed for electron microscopy as described in the text . (A-D)
Sequential stages in monocyte phagocytosis ofMOMP-liposomes . (A) At an early stage in the ingestion process, theMOMP-liposome is tightlyadherent
to the monocyte surface. (B and C). At later stages ofingestion, MOMP-liposomes are in the process of being internalized by monoryte pseudopods
extending circumpherentially about them . (D) In the final stage ofingestion, the MOMP-liposome is completely enclosed in a membrane-boundvacuole.
Magnification : A, x 100,000; B, x 76,000; C, x 48,000; and D, x 96,000.
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mophila and to both MOMP-liposomes and plain liposomes
(data not shown) .
OpsonizedMOMP-Liposomes Adhere to Human Monocytes .
The finding that MOMP-liposomes fix C3 and form C3-
MOMP complexes that are similar or identical to those formed
on intact L. pneumophila prompted us to examine ifMOMP
and C3 by themselves could mediate adherence to and phago-
cytosis of liposomes by human monocytes. To assay adher-
ence, we prepared MOMP-liposomes with radioiodinated
MOMP, opsonized them in various concentrations of serum,
washed them, incubated them with monorytes, and measured
monocyte-associated radioactivity (Fig. 8) . Adherence of
MOMP-liposomes to monocyte monolayers was serum de-
pendent, increasing from a level of-2% ofadded liposomes
in the absence of serum to a level of almost 11% in the pres-
ence of 2.5% serum in the representative experiment shown
in Fig . 8 . Adherence of opsonized liposomes to coverslips not
containing monorytes in control wells was independent of
the serum concentration used for opsonization, and ranged
from 1.2 to 1.5% . These data demonstrate thatMOMP and
C3 can mediate monocyte adherence of liposomes and that
MOMP-liposomes can serve as a model target particle for
studies of C3-dependent adherence by monocytes .
Opsonized MOMP-Liposomes Are Phagocytized by Human
Monocytes. To determine if monocytes phagocytize opsonized
MOMP-liposomes, we examined the interaction of mono-cytes and opsonized MOMP-liposomes by electron micros-
copy. MOMP-liposomes, opsonized and washed, were layered
over a pellet of mononuclear cells and centrifuged on top
of them at0°C . The samples were shifted to 37°C, incubated
for 3-6 min, and processed for electron microscopy (Fig . 9) .
Opsonized MOMP-liposomes were avidly ingested by mono-
cytes . In contrast, although accurate quantitation was not
possible in this assay, opsonized plain liposomes were infre-
quently ingested by monocytes, consistent with the much
lower level of C3 fixation of these liposomes . MOMP-
liposomes incubated in serum containing EDTA were rarely
if ever ingested by monocytes .
Most of theMOMP-liposomes were located intracellularly
in monocytes. However, many were observed in the process
of being internalized (Fig. 9) . These liposomes were ingested
by a conventional form of phagocytosis, i .e ., monocyte pseu-
dopods were observed fixed in the process of moving circum-
ferentially and more or less symmetrically about the liposomes .
Discussion
Previous studies have demonstrated that complement re-
ceptors CR1 andCR3 mediate phagocytosis of L . pneumophila
and have strongly indicated that fragments of complement
component C3 on the bacterium serve as ligands for these
receptors . However, evidence that C3 in nonimmune serum
fixes to L . pneumophila has been lacking. The current study
confirms that the bacterium does indeed fix C3 under these
conditions. The whole cell ELISA, which used opsonized
L . pneumophila as antigen, demonstrated that C3 is fixed to
the bacterium and that fixation takes place by the alternative
pathway of complement activation . Immunoblot analysis
confirmed that C3 is fixed to theL . pneumophila surface and
processed under our experimental conditions to at least the
iC3b stage.
Previous immunofluorescence studies did not demonstrate
complement fixation byL. pneumophila in nonimmune serum
(8) . In the present study, we suspect that the greater sensi-
tivity of the ELISA allowed us to detect a very small quan-
tity of fixed C3 . Consistent with this idea, comparative assays
of opsonized L . pneumophila, opsonized Escherichia coli
09:K29:H- (18), and opsonized zymosan have revealed that
L . pneumophila fixes'only about one-tenth the amount ofC3
as does E. coli or zymosan (Bellinger-Kawahara and Horwitz,
unpublished data) .
Our study also demonstrates that C3 fixes selectively to
MOMP on the surface ofL. pneumophila . Immunoblot anal-
ysis to opsonized L . pneumophila revealed a unique major C3-
acceptor molecule complex of-150 kD and, with the more
sensitive chicken anti-C3 antibody, a second potential com-
plex of -110 kD. These same two bands can be seen in au-
toradiograms ofintactL . pneumophila opsonized in fresh serum
spiked with radioiodinated C3 . The C3-acceptor molecule
complexes remained stable to hydroxylamine treatment, in-
dicating that C3 fixation takes place via an amide rather than
ester linkage. This in turn suggested that a protein rather
than a carbohydrate-containing molecule such as LPS was
serving as the acceptor molecule. Consistent with this, blotted
samples ofL . pneumophila and its components selectively fixed
C3 to the MOMP of L . pneumophila . L. pneumophila LPS
did not fix C3 .
Interestingly, C3 fixation may be targeted to specific por-
tions of the MOMP molecule . When immunoblots of cy-
anogen bromide fragments ofMOMP are incubated in serum,
some but not all MOMP fragments fix C3 (Bellinger-
Kawahara and Horwitz, unpublished data) .
We attempted by three independent approaches to iden-
tifyMOMP directly in the C3-acceptor molecule complex
formed on the surface of opsonized L . pneumophila . None
ofthese attempts was wholly successful . First,we attempted
on immunoblots ofopsonizedL. pneumophila to detectMOMP
in the 150- or 110-kD C3-acceptor molecule complex with
anti-MOMP antibody. This was unsuccessful, perhaps be-
cause the epitope recognized by the antibody was near the
thiolester linkage site or otherwise masked by the large C3
a chain covalently bound to themuch smaller acceptor mol-
ecule. Second, we attempted to immunoprecipitate C3-acceptor
molecule complexes from solubilized preparations ofopsonized
L. pneumophila with anti-C3 or anti-MOMP antibody. These
attempts were unsuccessful, presumably because of the small
amount of complex formed . Third, we attempted to iden-
tify the acceptor molecule by raising antibody to the C3-
acceptor molecule complex in the hope that some antibody
would be raised against the acceptor molecule portion and
that this antibody would recognize the acceptor molecule
on blots ofunopsonized L . pneumophila . We eluted the 150-
and 110-kD regions ofSDS-PAGE gels ofopsonized L . pneu-
mophila and immunized rabbits with the preparations . The
antisera thus obtained recognizedMOMP on immunoblots .
However, since MOMP forms a multimeric porin in the L .
pneumophila outer membrane, we could not rule out the pos-
sibility that the 150- or 110-kD regions of the SDS-PAGE
gels of opsonized L. pneumophila, which were used as an-
tigen, were "contaminated" with a small amount ofaggregated
MOMP and that antibody was raised against these molecules
rather than the C3-acceptor molecule complex .
Immunoblot analysis of C3-acceptor molecule complexes
formed onMOMP-liposomes provided indirect evidence that
the 150- and 110-kD complexes on blots ofopsonized L . pneu-
mophila containedMOMP This analysis revealed that MOMP-
liposomes form C3-acceptor molecule complexes in nonim-
mune serum ofthe same molecular weight (150 and 110 kD)
as those formed by intact L . pneumophila . Liposomes lacking
MOMP do not form these complexes in serum ; nor do
MOMP-liposomes in serum containingEDTA. This, together
with our finding that only theMOMP fixes C3 on immu-
noblots of whole L. pneumophila, provides strong evidence
thatMOMP is not only a major molecule ofL. pneumophila
that fixes C3, but the only major C3-fixing molecule.
A C3-acceptor molecule complex consisting ofCab linked
to monomericMOMPwould have a combined apparent mo-
lecular mass under reducing conditions of 139 kD (110,kD
C3b a chain plus 29-kD MOMP) . This combined apparent
molecular mass closely approximates the apparent molecular
mass ofthe major C3-acceptor molecule complex formed on
immunoblots of opsonized L . pneumophila and MOMP-
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sisting of iC3b linked to monomeric MOMP would have
a combined apparent molecular mass under reducing condi-
tions of 97 kD (68AD (x prime chain plus 29-kD MOMP) .
Again, this combined apparent molecular mass closely ap-
proximates the apparent molecular mass of the minor C3-
acceptor molecule complex formed on immunoblots of op-
sonizedL. pneumophila and MOMRliposomes (110kD) . The
SDS-PAGE system used in these experiments is accurate within
-10% of a given molecular mass, and therefore, the small
differences between the predicted and observed molecular
masses ofthe C3-acceptor molecule complexes are within the
range of experimental error.
To further explore the capacity ofMOMP to fix C3 and
mediate endocytosis, we reconstituted MOMP into unilamellar
liposomes and used theMOMRliposomes as a model system
for opsonization and phagocytosis experiments . ELISA and
immunoblot studies demonstrated thatMOMRliposomes fix
a relatively large amount of C3, whereas liposomes lacking
MOMP fix only a small amount of C3 . Our finding that
plain liposomes fix C3 is consistent with the recent report
by Cunningham et al . (19), who reported that liposomes with
a net positive charge and "fluid" membrane statemay fit com-
plement by the alternative pathway. For our liposomes, we
selected the lipid composition that was used in earlier studies,
which demonstrated that MOMP reconstituted into black
lipid membranes acts as a porin and retains normal porin func-
tion (10). This composition is such that the liposomes would
carry a net positive charge and have a fluid membrane state.
Liposome-MOMP complexes not only fix C3 in nonim-
mune serum, but once so opsonized, they adhere to and are
ingested by human monocytes. The data strongly indicate
that C3 mediates ingestion ofMOMP-liposomes by comple-
ment receptors on the monocytes. While it is theoretically
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